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Chromatin immunoprecipitation and global run-on
sequencing analysis of gut Microfold cells (M cells)
showed 12 previously unknown novel transcription factors
and, one of them, estrogen-related–receptor g, plays a crit-
ical role in M-cell differentiation. Lack of estrogen-related–
receptor g showed an immature and nonfunctional M-cell
phenotype.
BACKGROUND & AIMS: Microfold cells (M cells) are immu-
nosurveillance epithelial cells located in the Peyer’s patches
(PPs) in the intestine and are responsible for monitoring and
transcytosis of antigens, microorganisms, and pathogens.
Mature M cells use the receptor glycoprotein 2 (GP2) to aid in
transcytosis. Recent studies have shown transcription factors,
Spi-B and SRY-Box Transcription Factor 8 (Sox8). are necessary
for M-cell differentiation, but not sufficient. An exhaustive set of
factors sufficient for differentiation and development of a
mature GP2þ M cell remains elusive. Our aim was to under-
stand the role of polycomb repressive complex 2 (PRC2) as an
epigenetic regulator of M-cell development. Estrogen-rela-
ted–receptor g (Esrrg), identified as a PRC2-regulated gene,was studied in depth, in addition to its relationship with Spi-B
and Sox8.
METHODS: Comparative chromatin immunoprecipitation and
global run-on sequencing analysis of mouse intestinal organo-
ids were performed in stem condition, enterocyte conditions,
and receptor activator of nuclear factor k B ligand–induced M-
cell condition. Esrrg, which was identified as one of the PRC2-
regulated transcription factors, was studied in wild-type mice
and knocked out in intestinal organoids using guide RNA’s.
Sox8 null mice were used to study Esrrg and its relation to
Sox8.
RESULTS: chromatin immunoprecipitation and global run-on
sequencing analysis showed 12 novel PRC2 regulated tran-
scription factors, PRC2-regulated Esrrg is a novel M-cell–spe-
cific transcription factor acting on a receptor activator of
nuclear factor kB ligand–receptor activator of nuclear factor
kB–induced nuclear factor-kB pathway, upstream of Sox8, and
necessary but not sufficient for a mature M-cell marker of Gp2
expression.
CONCLUSIONS: PRC2 regulates a significant set of genes in M
cells including Esrrg, which is critical for M-cell development
and differentiation. Loss of Esrrg led to an immature M-cell
phenotype lacking in Sox8 and Gp2 expression. Transcript
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https://doi.org/10.1016/j.jcmgh.2021.05.014Tin immune surveillance of antigens, microorganisms,
and foreign pathogens that constantly thrive on the mucosal
surface of the intestinal tract. The GALT is the immune
initiation site against mucosal antigens and houses special-
ized gut immune epithelial cells known as microfold cells (M
cells). These cells occur on the epithelial surface of lymphoid
nodules of the GALT, which includes Peyer’s patches (PPs) in
the terminal ileum, solitary lymphoid nodules scattered
throughout the small intestine, the appendix, and rectal
patches in the terminal colon.1–3 The principal role of M cells
is the uptake and transcytosis of luminal antigens into the
GALT because they have a high phagocytic and transcytosis
capacity, which is responsible for the rapid transport of
bacterial antigens to antigen-presenting immature dendritic
cells.4,5 Subsequently, these dendritic cells undergo matura-
tion and activate antigen-specific naive T cells, which support
B-cell activation, ultimately resulting in the generation of IgA-
producing plasma cells.6 It has been shown previously that
the absence of M cells or their antigen uptake receptor
glycoprotein 2 (GP2) impairs the mucosal immune responses
by T cells in mice infected with Salmonella enterica serovar
Typhimurium. This is predominantly owing to a lack of
bacterial transcytosis by the mature GP2 receptor into the
GALT.7,8 Correspondingly, perturbances in transcytosis of
Yersinia enterocolitica in PPs were observed in Allograft in-
flammatory factor 1 (Aif1) mutant mice.9 Recently, it was
shown that M cells self-regulate their differentiation by
expressing osteoprotegerin, a soluble inhibitor of receptor
activator of nuclear factor-kB ligand (RANKL), which sup-
presses the differentiation of adjacent follicle-associated
epithelium (FAE) cells into M cells. This self-regulatory ma-
chinery of M-cell density is necessary because Opg/ mice
are highly susceptible to mucosal infection by pathogenic
bacteria because of the augmentation of bacterial trans-
location via M cells.10 Overall, defects in M-cell–dependent
antigen uptake led to a decrease in production of antigen-
specific secretory IgA in the gut.5,9,11
M-cell differentiation from cycling intestinal crypt cells
that express Leucine Rich Repeat Containing G Protein-
Coupled Receptor 5 (Lgr5) and receptor activator of nuclear
factor kB (RANK) receptors is induced by the RankL. RankL
is secreted by stromal cells, also known as M-cell inducer
cells or immune cells in the subepithelial dome.1,12 RankL-
deficient mice have very few M cells, but exogenous
administration of recombinant RankL was able to mitigate
that loss.13 RankL binding to Rank receptor leads to the
activation of the intracellular adaptor molecule of RANK;
TNF Receptor Associated Factor 6 (TRAF6), which in turn
leads to activation of both canonical (RelA/p50 hetero-
dimer) and noncanonical nuclear factor-kB (NF-kB) (RelB/p52 heterodimer) activation.14–16 The canonical RelA/p50
activation led to expression of early M-cell markers such as
Marcks like 1 (MarcksL1) and Chemokine (C-C motif) ligand
9 (CCL9), whereas noncanonical RelB/p52 activation led to
expression of Spi-B and Sox8 transcription factors, both
deemed essential to maturation of M cells.8,16 Along with
RankL, expression of Spi-B and Sox8 are essential for the
development of GP2-positive M cells. Both Spi-B and Sox8
mutant mice showed the absence of mature M cells with
GP2, whereas Marcksl1þAnnexinVþ immature M cells were
intact.7,8,17,18 Spi-B-/- still showed Sox8 expression and
Sox8-/- mice expressed Spi-B, and even though both mice
had activation of both NF-kB transcription pathway, p50/
RelA, and p52/RelB, they still showed an immature M-cell
phenotype lacking the expression of Gp2.16 Taken together,
despite their critical role in the onset of mucosal immune
responses, M-cell development and their differentiation into
maturity have not yet been fully characterized, partly
because of their rarity in the gastrointestinal tract.19
Importantly, the sole overexpression of Spi-B and Sox8 are
not sufficient for the induction of GP2 receptor (ie, M-cell
maturation), suggesting that additional M-cell–specific
transcription factors are needed.8
Intestinal cell differentiation, development, and func-
tionality are regulated by several factors, one of the indis-
pensable ones being polycomb group proteins. Polycomb
group proteins are essential for embryonic stem cell self-
renewal and pluripotency, but they also are necessary for
the maintenance of cell identity and cell differentiation
throughout life.20 They broadly form 3 groups of polycomb-
repressive complexes (PRCs) known as PRC1, PRC2, and
polycomb repressive DeUBiquitinase, each of these com-
plexes reassemble chromatin by explicitly defined mecha-
nisms that involve variable configurations of core and
accessory subunits. This configuration is shown by the way
PRC2 catalyzes trimethylation of histone H3 lysine 27
(H3K27me3) and presents a binding site for PRC1 in em-
bryonic stem cells.21 Previously, it has been shown that
PRC2 played a repressive role of expression of develop-
mental regulators necessary for cell differentiation.22
Interestingly, genes critical for cell identity lose their
methylation on H3 lysine K27, whereas genes that regulate
2021 M Cell Development 875alternate cell types keep their methylation and remain
repressed.23 In human embryonic stem cells, Wingless/
integrated (Wnt)-signaling genes are bound by PRC2, anal-
ogously this also is shown in adult tissues (eg, in adipo-
genesis).24 The integrity and homeostasis of healthy
intestine is regulated partly by canonical Wnt signaling and
it also has been shown that secretory and absorptive pro-
genitor cells show comparable levels of histone modifica-
tions at most of the same cis elements in the genome.25 Our
study and others have found out how PRC2 regulates a
substantial subset of genes that were involved in canonical
Wnt signaling and contributed to the differentiation of Lgr5-
expressing stem cells to secretory and absorptive cell types
in the intestine.26–28
To further understand the complexity of M-cell differ-
entiation, we asked if PRC2 regulates M-cell differentiation.
We used high-throughput tools such as chromatin immu-
noprecipitation sequencing (ChIP-seq) and global run-on
sequencing (Gro-seq) to identify factors that contribute to
the function and development of M cells in the intestine. We
identified a total of 12 transcription factors that are regu-
lated by PRC2 exclusively during M-cell differentiation, of
which 6 were down-regulated and 6 were up-regulated. One
of the M-cell–specific transcription factors, estrogen-related
receptor g (Esrrg), was found to be essential for the dif-
ferentiation of mature GP2þ M cells in vitro. We found that
Esrrg was expressed exclusively in M cells in Peyer’s
patches and was shown to be critical for the activation of
Sox8 transcription factor. Esrrg expression was intact even
in Sox8-deficient mice, and was dependent on the activation
of noncanonical NF-kB signaling. These observations show
that Esrrg is a crucial player in the differentiation and
functionality of a mature GP2þ M cell.
Results
PRC2 Does Not Restrict M-Cell Differentiation
We and others have previously shown that disrupting
PRC2 activity leads to a precocious expression of terminal
differentiation markers of intestinal epithelium.27–29 More-
over, PRC2 has been shown to preserve intestinal pro-
genitors and restrict secretory cell differentiation.26
Contrary to absorptive cell differentiation, when organoids
were treated with RANKL the level of expression of PRC2
members Enhancer of Zeste homolog 2 (Ezh2) and Supressor
of Zeste homolog 12 (Suz12) were comparable with the
levels in organoids grown in standard organoid culture me-
dia with ENR500 (epidermal growth factor, Noggin, R-
spondin 500 ng/mL) (Figure 1A). Next, we asked if PRC2
inhibition (Figure 1B) can augment M-cell differentiation and
we saw that, contrary to enterocyte differentiation, expres-
sion of all M-cell markers are down-regulated when the
activity of PRC2 is inhibited pharmacologically during the
RANKL-induced, M-cell differentiation (Figure 1C).27,29
PRC2 Regulated Genes During M-Cell
Differentiation
It has been shown previously that PRC2 regulates tran-
scription factors that are necessary to intestinal stem cellmaintenance and differentiation (eg, Achaete-Scute Family
BHLH Transcription Factor 2 [Ascl2]27,30 and Atonal BHLH
Transcription Factor 1 [Atoh1]26). Because PRC2 mainly
regulates genes involved in development or signaling,31 we
reasoned that identifying genes regulated by PRC2 during
M-cell differentiation might show the gene network neces-
sary to this cell type in the intestine. M-cell differentiation
was induced in mouse intestinal organoids with recombi-
nant RankL, gene expression was analyzed with Gro-Seq,
and PRC2 target genes were identified with ChIP-seq by
using H3K27me3 antibody. Genes expressed differentially
after RankL treatment are shown in Figure 2A
(Supplementary Table 1). ChIP-seq performed with
H3K27me3 antibody showed a significant number of genes
regulated by PRC2 for M-cell differentiation. When
comparing our 3 different Chip-seqs (organoids in Wnt,
epidermal growth factor, Noggin, R-spondin, Chir [WENRC]
media [stem cell conditions]; epidermal growth factor,
Noggin, R-spondin, Wnt inhibitor IWP2 [ENRI] media
[enterocyte conditions]; and RankL media [M-cell differen-
tiation]), we observed that, in M cells, 38 (9.2%) and 35
(10.3%) genes were up-regulated but silenced by PRC2 in
WENRC and ENRI, respectively. Thirty-two PRC2 target
genes were uniquely up-regulated during M-cell differenti-
ation but not in enterocyte differentiation. Forty-six (27.7%)
and 52 (11.5%) PRC2 target genes were silenced in orga-
noids treated with RANKL, but expressed in stem cell and
differentiation conditions, respectively. Forty-two genes
were uniquely silenced in M-cell, but not in enterocyte,
differentiation. PRC2 target genes are shown in
Figure 2B–D, and the M-cell–specific accumulation and
ablation of H3K27me3 signal in the gene promoters are
shown in Figure 2E. Gene ontology analyses indicated that
PRC2 regulates many DNA-binding transcription factors
during M-cell differentiation (Figure 2G). A total of 12
transcription factors were expressed differentially: 6 were
silenced by PRC2 in M cells and 6 were expressed specif-
ically in M cells but repressed by PRC2 in organoids grown
in both stemness and enterocyte conditions. The 6 PRC2
target genes expressed specifically in M cells were Sox8,
Atoh8, Esrrg, Smad6, Maf, and Zfp819. The 6 genes silenced
were Hoxb5, Hoxb9, Sp9, Sp5, Nr4a1, and Atf3.Esrrg Is Expressed in M Cells and Induced by
Rank–RankL Signaling
Of the 6 transcription factors that were expressed spe-
cifically in M cells in a PRC2-dependent manner (Figure 2A
and B), Esrrg turned up as one of the most highly expressed
PRC2-regulated transcription factors during M-cell differ-
entiation (log2 fold changes, –6.64 RankL vs ENRI and –4.76
in RankL vs WENRC comparisons) (Figure 3A). Immuno-
histochemistry analysis for Esrrg in PP showed that Esrrg
was localized in the FAE cells (Figure 3B). RNA was isolated
from FAE isolated from PP and villus epithelium and the
reverse-transcription quantitative polymerase chain reac-
tion (RT-qPCR) analysis confirmed that the Esrrg was
enriched significantly in FAE (Gp2 as a marker) when
compared with villus epithelium (Figure 3C). To ascertain
Figure 1. PRC2 members are expressed in M cells. (A) RT-qPCR analyses of the expression of Suz12 and Ezh2 in mouse
intestinal organoids grown in ENR, ENRþRankL, and ENRI conditions. (B) Immunoblot of H3K27me3 and H3 in organoids
treated with Ezh2 inhibitor (EI1) inhibitor. Data are representative of 2 independent experiments. (C) RT-qPCR analyses of the
expression of M-cell marker genes in RankL-treated organoids with or without EZH2 inhibitor EI1. An unpaired 2-tailed Student
t test was performed. *P < .05, **P < .01, and ***P < .005, N ¼ 3 independent experiments. Values are presented as means ±
SD. Gapdh, glyceraldehyde-3-phosphate dehydrogenase; mRNA, messenger RNA.
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analyses were performed for organoids before and after 4
days of RankL treatment. The expression of Esrrg, together
with M-cell marker Gp2, was induced significantly with
RankL treatment (Figure 3D). To confirm that Esrrg
expression was regulated specifically by Rank-Rankl
signaling, we generated Rank-deficient mouse intestinal
organoids using the Lenti-V2 CRISPR/Cas9 plasmid and
found that in Rank-deficient organoids, RankL treatment did
not induce the expression of Esrrg (Figure 3E). The Rank
knockout (KO) organoids were validated by immunoblot
analysis (Figure 3F).Noncanonical NF-kB Activation Is Necessary and
Sufficient for Esrrg Expression
Rank–RankL signaling was shown previously to activate
canonical as well as noncanonical NF-kB pathways. Lym-
photoxin-b receptor (LTbR) signaling was implicated in
inducing both classic p50–RelA and noncanonical p52–RelB
heterodimers in PP.32 Mouse intestinal organoids were
grown for 3 days in the presence of LTa1b2, the ligand of
LTbR, and we observed that, similar to Spi-B, Esrrg
expression also was increased significantly (Figure 4A). To
identify if canonical NF-kB had a role in Esrrg expression
specifically, mouse organoids were grown in the presence
and absence of RankL and SC-514, a specific inhibitor of IkB
kinase-b (inhibitor of nuclear factor kappa B).33 We found
that inhibiting canonical NF-kB with SC-514 completely
abrogated the expression of Esrrg (Figure 4B), as was re-
ported similarly for Spi-B.16 Both p50-RelA and p52-RelB
overexpression led to increased expression of Esrrg
(Figure 4C). It has been shown previously that p50/RelA
(canonical NF-kB) directly targets the transcription of
RelB.34 The treatment of p52/RelB overexpression organo-
ids with SC-514 could not suppress the activation of Esrrg
(Figure 4D). To conclude, these data indicate that nonca-
nonical NF-kB is necessary and sufficient to induce Esrrg.Esrrg Expression Is Required for Sox8 Activation
and Maturation of M Cells
Given that Esrrg was expressed prominently in PP and
regulated by noncanonical NF-kb expression, we sought to
see if abolition of Esrrg had any effect on M-cell differenti-
ation and development. To investigate this, mouse intestinal
organoids deficient in Esrrg were generated by LentiCRISPR
V2 CRISPR-Cas9 genome editing. Targeting of Esrrg by the
guide RNA selected (Figure 5A) resulted in a significant
reduction in expression of Esrrg protein (Figure 5B). Esrrg-
deficient organoids were grown in the presence and absence
of RankL for 3 days. RT-qPCR analysis showed that Gp2 was
nearly absent and Sox8 expression was reduced signifi-
cantly in Esrrg-targeted organoids (Figure 5C). Gp2 and
Sox8 immunostaining in Esrrg-targeted organoids showed
an absent and reduced expression, respectively (Figure 5D
and E). However, expression of Spi-B and TNF Alpha
Induced Protein 2 (Tnfaip2) remained unaffected in the
Esrrg-deficient organoids (Figure 5C and E). Early M-cell
differentiation markers such as CCL20, CCL9, and MarcksL1
were affected significantly by the lack of Esrrg as well
(Figure 5F). Aif1, which is a regulatory gene for transcytosis
in M cells, also was found to be affected severely by lack of
Esrrg expression (Figure 5F). Our observations showed that
Esrrg is required for the expression of Sox8 and for the early
markers as well as late maturation steps in M-cell differ-
entiation. To validate for off-target effects, we knocked out
Esrrg with a second guide RNA; comparable results were
observed (Figure 6A and B).Esrrg Acts Upstream of Sox8 Expression
Spi-B and Sox8 were found to be 2 key transcription
factors involved and essential for M-cell differentiation
and regulation of expression of other M-cell–associated
genes.7,8,17,18 Spi-B and Sox8 mutant mice lacked GP2þ
mature M cells and were unable to transcytose antigens.
However, it was observed that Spi-B was dispensable to
2021 M Cell Development 877the expression of Sox8 even though Spi-B expression
was reduced moderately in the Sox8 mutant mice.8 To
investigate if Esrrg is affected by knockout of Sox8, RNA
was isolated from FAE of PPs from Sox8þ/þ and
Sox8-/- mice. RT-qPCR analysis of FAEs from PPs ofSox8þ/þ and Sox8-/- showed that the expression of
Esrrg was higher in Sox8-/- mice (Figure 7A). Organoids
isolated from Sox8þ/þ and Sox8-/- mice were treated
with RankL and expression of Esrrg expression was
analyzed by RT-qPCR and Western blot. The analysis
878 George et al Cellular and Molecular Gastroenterology and Hepatology Vol. 12, No. 3showed Esrrg expression was intact and similar to the
in vivo data (Figure 7B and C). This suggests that Esrrg
acts upstream of Sox8 and could play a role in the
activation of Sox8. Next, we explored how Esrrg was
affected by Spi-B. Spi-B–deficient organoids were
generated by LentiCRISPR V2 genome editing and grown
in the presence and absence of RankL. qPCR analysis
showed that Esrrg was affected moderately by the lack
of Spi-B (Figure 7E). Western blot analysis also indi-
cated that Esrrg was expressed less in Spi-B–deficient
organoids (Figure 7F). Spi-B KO organoids were vali-
dated by immunoblot analysis (Figure 7D).
Overexpression of Esrrg Is Not Sufficient for
Gp2þM Cells but Esrrg Agonist Augmented Gp2
Expression
Spi-B expression in Sox8 KO mice and Sox8 expression in
Spi-B KO mice did not lead to a mature GP2þ M-cell
phenotype in either of these mice.7,8 Because we found that
the expression of Gp2 was dependent on Esrrg (Figure 5C),
we sought to investigate if the overexpression of Esrrg alone
could lead to up-regulation of Sox8 or Gp2 expression. Esrrg
cloned into CSII-CMV-MCS-IRES2-Bsd overexpression vector
was transduced into mouse intestinal organoids. RT-qPCR
analysis showed that Esrrg alone was not adequate
enough to induce Gp2 or other M-cell–specific transcription
factor such as Spi-B or Sox8 (Figure 8A). Esrrg is an orphan
nuclear receptor without known natural ligands. However,
4-hydroxytamoxifen has been shown to bind and inhibit
Esrrg activity and phenolic acyl hydrazones; GSk4716 was
identified as an agonist that enables the activation of other
co-activators and other downstream targets.35,36 The
antagonist 4-hydroxytamoxifen along with RankL induced a
similar result to the lack of Esrrg protein, Spi-B remained
unaffected, although Sox8 and Gp2 were affected signifi-
cantly (Figure 8B). Organoids treated with agonist GSK4716
and RankL did not show a significant increase in Sox8 or
Spi-B expression, however, Gp2 expression was augmented
slightly with GSK4716 (Figure 8C).
Discussion
Our data show the PRC2-regulated genes during the
differentiation of intestinal microfold cells. Because PRC2 isFigure 2. (See previous page). PRC2-regulated genes durin
during M-cell differentiation detected with Gro-Seq. Signal is de
RankL treatment. X-axis and Y-axis indicate the log2 fold chang
are marked (Gro-seq with log2 fold change cut-off value at ±2
removed to show only RankL-specific regulation. (B) Genes up-r
Heatmap of differentially expressed (Gro-seq with log2 fc cut-o
(log2 fc ±2, P < 10-6) genes in RankL, ENRI, and WENRC-trea
down-regulated by H3K27me3 in M cells and enterocytes comp
in stem cells and M cells compared with enterocytes. Compos
bases around transcription start sites in genes (E) specifically si
cells. (E) Example genes Lgr5 (below) and (F) Sox8 (below). (G)
PRC2-target genes between M cells and stem cells (Gro-seq lo
molecular function and biological process. LogFC shows the d
ISC, intestinal stem cells; mRNA, messenger RNA.the master regulator of development, it is very likely that
many of the identified PRC2 targets that are induced spe-
cifically in M cells contribute to the maturation of this cell
type. Transcription factors usually are expedient to devel-
opment, and we identified 6 PRC2-regulated transcription
factors up-regulated specifically after the RankL-induced M-
cell differentiation. Among those was previously identified
transcription factor Sox8, which we also here showed to be
necessary for M-cell differentiation.8 Because Esrrg was
clearly the most highly induced PRC2 target gene during M-
cell differentiation, we studied it in more detail in intestinal
organoids and showed that it is indispensable to the
maturation of intestinal stem cells into GP2þ M cells. Esrrg
is a member of the ESRR nuclear-receptor family, which also
includes ESRRA and ESRRB.37 This subfamily of orphan
nuclear receptors has been shown to share target genes,
coregulatory ligands, and sites of action with ERs. Esrrg was
implicated to control macrophage function indirectly
through regulation of intracellular iron. In response to Sal-
monella typhimurium infection, hepatic expression of the
hormone hepcidin is up-regulated by ERRg downstream on
interleukin 6 signaling.34,38 However, no prior data about
the expression and function of Esrrg in M cells and M-cell
induced transcytosis of antigens exist. We defined the spe-
cific expression of Esrrg by M cells in mouse FAEs and how
its expression was up-regulated by induction of RankL and
was under the influence of the RankL–Rank pathway. The
loss of Esrrg led to a lack of expression of the GP2 receptor
in Esrrg KO organoids, which is characteristic of a mature M
cell, and a lack of GP2 in M cells has been shown to result in
attenuation of antigen sampling and transcytosis. This dis-
tribution of Esrrg along with the phenotype of Esrrg KO
organoid highlights a critical role for Esrrg in the maturation
of functional M cells.
RelB/p52 activation was shown to up-regulate Spi-B.16
Similarly, here we show that Esrrg also is regulated by the
activation of the noncanonical NF-kB pathway. We believe
that the expression of Esrrg and Spi-B is regulated down-
stream in parallel by RankL-Rank-RelB/p52 signaling
(Figure 9). Esrrg has been shown to behave as a constitutive
activator of transcription.39 Here, we show that Esrrg is
needed for the activation of Sox8. Sox8 was discovered to be
indispensable for the expression of GP2, and Sox8 KO mice
showed a decrease in uptake of antigens and a significantg M-cell differentiation. (A) Differentially expressed genes
picted by volcano plot comparing organoids before and after
e and –log10 adjusted P value. Differentially expressed genes
, P < .0001). Up-regulated genes from ENRI conditions were
egulated in M cells compared with stem cells and enterocytes.
ff value at ±2 and P value < .0001) and H3K27me3 regulated
ted organoids showing centered log2 fold change. (C) Genes
ared with stem cells. (D) Genes down-regulated by H3K27me3
ite enrichment analysis of H3K27me3 signal density þ-4000
lenced by PRC2 in M cells and (F) specifically expressed in M
Gene ontologies enriched (P < .05) in differentially expressed
g2 fc ±2, P < .0001, and H3K27me3 log2 fc ±2, P < 10-6) in
irection of gene expression between M cells and stem cells.
Figure 3. Esrrg is expressed in FAE in PPs and is dependent on Rank–RankL signaling. (A) H3K27me3 occupancy at CpG
islands spanning the promoter and first exon of the Esrrg gene in organoids treated with RankL (M cells) or inhibited with IWP2
(enterocytes) or treated with Wnt3a and Chir99021 (crypt/intestinal stem cells). Below, pre–messenger RNA (mRNA)
expression of Esrrg in organoids treated as described earlier (y-axis: normalized tag count, ENR500 ¼ R-spondin 500 ng/mL,
R100 ¼ Rankl 100 ng/mL). (B) Section of PP from wild-type mice stained with Esrrg antibody. Arrowheads indicating Esrrg
expression in the nuclei of M cells in FAE. (C) RT-qPCR analysis of Esrrg and Gp2 in the FAE and villous epithelium (VE) from
C57BL/6JRj mice (N ¼ 3 from wild-type mice). (D) Organoids generated from wild-type mice were stimulated with 100 ng
RankL for 4 days. Esrrg and Gp2 expression was examined by qPCR analysis. (E) Rank KO organoids and Scrambled
organoids generated by lentiCRISPR v2 were incubated with RankL for 4 days, Esrrg and Gp2 expression was analyzed by
quantitative RT-qPCR. (C–E) An unpaired 2-tailed Student t test was performed for 3 independent experiments. ****P < .0005,
***P < .005, and **P < .01. Values are presented as means ± SD. (F) RANK protein expression in RANK KO and Scrambled
cells generated by lentiCRISPR v2 genome editing in C57BL/6JRj intestinal organoids. Organoid lysates were analyzed by
Western blot. Gapdh, glyceraldehyde-3-phosphate dehydrogenase.
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Figure 4. Esrrg expression is induced by RelB/p52 activation. (A) Lta1b2 prominently up-regulated the expression of Esrrg in
organoids. Organoids from C57BL/6JRj mice were stimulated with LTa1b2 for 3 days, and the gene expression was analyzed by
qPCR. (B) Organoids from wild-type mice were stimulated with RankL for 3 days in the absence or presence of 125 mmol/L SC-
514. Gene expression was analyzed by qPCR. (C) Organoids were transduced to express classic and noncanonical NF-kB and
the expression of Esrrg and Spi-B (control) are represented relative to glyceraldehyde-3-phosphate dehydrogenase (Gapdh). (D)
Organoids expressing p52 and RelB in the presence of SC-514 for 3 days, and the expression of Esrrg and Spi-B was analyzed
by qPCR. Values in all are presented as the means ± SD and an unpaired 2-tailed Student t test was performed, N ¼ 3 in-
dependent experiments. *P < .05, **P < .01, ***P < .005. Ctrl, control; DMSO, dimethyl sulfoxide.
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bind directly to the Gp2 promoter along with SpiB.8 The
significant decrease in Sox8 expression could explain why
Esrrg KO organoids were not able to activate Gp2. Sox8
expression alone cannot lead to an increase in Gp2
expression because enhancer activation by SOX proteins
require DNA binding partners specific for each member of
the SOX family. These DNA binding partners aid in stabi-
lizing the SOX family to their target regions.40 This suggests
that Esrrg-activated Sox8 requires another molecule
downstream of Spi-B or through another pathway to bind to
Gp2 to induce its expression, however, further exploration is
required to confirm this. Esrrg overexpression alone did not
lead to expression of Sox8, confirming the need of a ligand
and/or other factors to activate downstream targets.
A major portion of our investigation of Esrrg in M cells
was conducted in vitro and Esrrg ablation in mousemodels is required to further ascertain its role. Interest-
ingly, Sox8 deficiency did not affect early M-cell markers,
however, Esrrg KO organoids showed a drastic decrease in
expression of early M-cell markers such as CCL9 and
MarcksL1. Mature marker Gp2-receptor expression was
decreased significantly as well. The loss of Aif1 expression
in Esrrg KO means that transcytotic capacity of the M cells
would be affected as well. Esrrg KO organoids also
impaired the expression of Sox8, and in the Sox8 KO mice
we observed that Esrrg expression still was intact and
even observed to have a higher expression in vivo and
in vitro, suggesting that Esrrg was not affected by the
absence of Sox8 and possibly could be acting upstream of
it. The significance of Esrrg was confirmed further with
our antagonist and agonist experimental study. Although
tamoxifen is known to trigger multiple signaling pathways
in the cell, it has been identified as an antagonist for Esrrg
2021 M Cell Development 881receptor; tamoxifen was able to significantly decrease the
expression of Gp2 and Sox8 similar to the Esrrg KO
organoids. The treatment of intestinal organoids with
RankL and Esrrg agonist GSK4716 augmented the
expression of Gp2 when compared with organoids with
just RankL treatment. This could be because GSK4716binds to Esrrg and activates several other unknown
downstream targets that combine to attenuate Gp2
expression. Esrr family members are known to be orphan
receptors, meaning they might not need a ligand for its
function, or the ligand remains unknown. Overexpression
of Esrrg did not lead to an increase in Sox8 expression or
Figure 6. Esrrg abolition by genomic RNA (gRNA) 2 impairs Sox8 activation and the functional maturation of M cells.
(A) Esrrg protein expression in Esrrg KO2 with gRNA 2 and Scrambled cells generated by lentiCRISPR v2 genome editing in
C57BL/6JRj intestinal organoids. Organoid lysates were analyzed by Western blot. (B) qPCR analysis of M-cell–associated
genes expressed in Esrrg KO2 and Scrambled intestinal organoids stimulated by RankL for 4 days. GAPDH, glyceraldehyde-3-
phosphate dehydrogenase. Values in all are presented as the means ± SD. Unpaired 2-tailed Student t test, N ¼ 3 independent
experiments *P < .05, **P < .01.
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differentiation, presumably because a specific ligand might
be necessary. However, further studies are needed to
prove this.
In conclusion, we identified several previously un-
known PRC2-regulated genes implicated in M-cell dif-
ferentiation. One of the genes we identified, Esrrg, is aFigure 5. (See previous page). Abolition of Esrrg impairs S
(A) Schematic representation of Esrrg KO design by CRISPR-Ca
and genomic position are indicated. (B) Esrrg protein expression
genome editing in C57BL/6JRj intestinal organoids. Organoid ly
cell–associated genes expressed in Scrambled and Esrrg KO st
Spi-B (red), Sox8 (red), and GP2 (green) in Scrambled organoids
and without 100 ng RankL. Scale bars: 100 mm. (E) The number o
organoids was compared between ScrþR100– and Esrrg KOþR
independent experiments. (F) qPCR analysis of early markers of
RankL for 4 days. Values in all are presented as the means ±
periments. *P < .05, **P < .01, ***P < .005, ****P < .0005. GA
single guide RNA.key transcription factor, and therefore is required for
the functional development and M-cell differentiation
that is pertinent for constant surveillance of the
mucosal lining of the gastrointestinal tract. We believe
that the further exploration of other activators of Gp2
will lead to better elucidation of M-cell maturation and
antigen transcytosis. This will create the potential toox8 activation and the functional maturation of M cells.
s9 genome editing in mouse intestinal organoids. Exon, intron,
in Esrrg KO and Scrambled cells generated by lentiCRISPR v2
sates were analyzed by Western blot. (C) qPCR analysis of M-
imulated by RankL for 4 days. (D) Immunostaining images for
with and without 100 ng RankL for 4 days and Esrrg KO with
f GP2þM cells and Sox8þM cells per length of epithelium of
100–treated organoids (n ¼ 3). Images are representative of 3
M-cell–associated genes expressed in vitro in the presence of
SD. Unpaired 2-tailed Student t test, N ¼ 3 independent ex-
PDH, glyceraldehyde-3-phosphate dehydrogenase; sgRNA,
Figure 7. Esrrg expression and its relation to other M-cell developmental markers Spi-B and Sox8. (A) Esrrg expression
was unaffected by lack of Sox8 expression. qPCR analysis of Esrrg and Gp2 in the FAE and villous epithelium from Sox8þ/þ
and Sox8-/- mice. (B) Organoids generated from Sox8þ/þ and Sox8-/- mice were stimulated with and without RankL for 4 days.
Esrrg expression was examined by qPCR analysis. (C) Organoids isolated from Sox8 wild-type and Sox8 KO mice were lysed
and analyzed by Western blot for Esrrg expression. (D) Spi-B protein expression in Spi-B KO and Scrambled cells generated by
lentiCRISPR v2 genome editing in C57BL/6JRj intestinal organoids. Organoid lysates were analyzed by Western blot. (E) qPCR
analysis of Esrrg in a Spi-B KO intestinal organoid by lentiCRISPR v2. (F) Organoid lysates for Esrrg in Scrambled and SpiB KO
organoids were analyzed by Western blot. Values in all are presented as the means ± SD. Unpaired 2-tailed Student t test, N ¼
3. *P < .05, **P < .01. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; rRNA, ribosomal RNA.




C57BL/6JRj mice were purchased from Janvier labs (Le
Genest-Saint-Isle, France) andweremaintainedwith constant
breeding. The Bac-Cre-ERT2;Sox9f/f;Sox8-/-;Rosa26Eyfp
micewere a gift fromRaphael Jimenez (University of Granada,
Granada, Spain). These mice were backcrossed with
C57BL/6JRj to isolate the Sox8-/- allele. Sox8þ/- werebred to obtain Sox8-/- and littermate controls: Sox8þ/- and
Sox8þ/þ. F1–4 mice were used for gene or protein expres-
sions. Genotyping of the wild-type, heterozygous, and
deleted alleles was performed by PCR with the
following primers: F1, 5’-GTCCTGCGTGGCAACCTTGG-3’; R1,
5’-GCCCACACCATGAAGGCATTC-3’; and F3, 5’-TAAAAA
TGCGCTCAGGTCAA-3’. Conventional conditions were
observed for the maintenance of these mice at the pathogen-
free animal facility of the faculty of Medicine and Health
Technology. All animal experiments were approved by the
Finnish National Animal Experiment Board (permit ESAVI/
5824/2018).
Figure 8. Esrrg alone is not sufficient for maturation of Gp2D M cells. (A) Intestinal organoids were dissociated and
transduced by lentivirus encoding Esrrg. qPCR analysis of Spi-B, Sox8, and GP2 showed no significant changes. (B) Orga-
noids were grown in the presence and absence of 100 ng/mL Rankl and 1 um tamoxifen-antagonist of Esrrg. Spi-B, Gp2, and
Sox8 expression were analyzed with RT-qPCR. (C) Intestinal organoids from mice were grown in the presence and absence of
100 ng/mL Rankl and 10 um GSK 4718-agonist of Esrrg for 3 days. Spi-B, Gp2, and Sox8 were analyzed with RT-qPCR.
Values are presented as the means ± SD. Unpaired 2-tailed Student t test, N ¼ 3. *P < .05, **P < .01, ***P < .005, ****P <
.0005. Ctrl, control; DMSO, dimethyl sulfoxide; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; O/E, overexpression.
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Intestinal crypt isolation and culture techniques were
observed as previously established by the protocols of Sato
and Clevers41 and de Lau et al.17 Mouse duodenum were cut
longitudinally, and the villi were gently scraped off with 2
glass slides. After a couple of phosphate-buffered saline(PBS) washes, they were cut into 2-mm pieces and pipetted
up and down 5 times in 15 mL PBS with a 10-mL pipette,
this step was repeated 3 times with fresh PBS. The pieces
were incubated in 10 mmol/L EDTA in PBS for 20 minutes,
rocking at room temperature. The pieces were vigorously
suspended in cold PBS and the mixture was strained
Figure 9. PRC2 regulates the differentiation of M cells. In
the absence of Rank–RankL signaling, Esrrg and Sox8 genes
are repressed by PRC2 in the intestinal epithelium. When
migrating progenitors with Rank receptors bind to RankL in
PPs, this induces NF-kB signaling, leading to loss of
H3K27me3 from the gene promoters and activation of Esrrg
and Sox8. Sustained expression of Sox8 and GP2 and dif-
ferentiation of M cells is dependent on Esrrg. ISC, intestinal
stem cells.
2021 M Cell Development 885through a 70-mm cell strainer (cat no: 22363548; Fisher
Scientific, Waltham, MA). This mixture was enriched to crypt
fraction through centrifugation at 150  g for 5 minutes.
The enriched crypts were embedded in Matrigel (cat no:
356255, lot 9119006; Corning, Corning, NY), and 30 uL
were plated on a 24-well plate. Crypts were cultured in an
optimal medium consisting of advanced Dulbecco’s modified
Eagle medium/F12 (cat no: 12634010; Thermo Fisher Sci-
entific, Waltham, MA) that contained HEPES (10 mmol/L,
cat no: 15630-080; Sigma-Aldrich, St. Louis, MO), Glutamax
(2 mmol/L, cat no: 35050-038; Thermo Fisher Scientific),
penicillin-streptomycin (100 U/mL, cat no: 11659990;
Sigma-Aldrich), B-27 supplement minus vitamin A (cat no:
17504-044; Thermo Fisher Scientific), N-2 supplement (cat
no: 17502-001; Thermo Fisher Scientific), N-acetylcysteine
(1 mmol/L, cat no: A9165, lot SLCB3719; Sigma-Aldrich),
recombinant murine epidermal growth factor (50 ng/mL,
cat no: PMG8043, lot 2135273; Gibco, Waltham, MA), re-
combinant murine Noggin (100 ng/mL, cat no: 250-38;
PeproTech), and recombinant mouse R-spondin 1 (1 mg/mL,
cat no: 120-38; R&D Systems, Minneapolis, MN). Media were
changed every 2 days. For M-cell differentiation, recombi-
nant mouse RankL (100 ng/mL, cat no: 315-11; PeproTech,
Cranbury, NJ) was added to the media and incubated for 4
days. PRC2 was inhibited by addition of 5 mm of Ezh2 in-
hibitor (cat no: CAS 1418308-27-6 C; Calbiochem Chemicals,
San Diego, CA). For activation of NF-kB, human LTa1b2 (1
mg/mL, cat no: 8884-LY; R&D Systems) was added into
organoid cultures. Restriction of IkB kinase-b activity was
achieved by adding SC-514 (125 mmol/L, cat no: 354812-
17-2; Selleckchem, Houston, TX) for 3 days.42 (Z)-4-
Hydroxytamoxifen (1 mm, cat no: 68392-35-8; Sigma-
Adrich) was used as an antagonist of Esrrg, and GSK 4716
(10 mm, cat no: 101574-65-6; Sigma-Aldrich) was used as an
agonist of Esrrg.ChIP-Seq Analysis
Intestinal organoids (in ENR500, ENRI, and RankL
culturing conditions) were isolated from Matrigel with Cell
Recovery Solution (Corning). This was followed by washes
with cold PBS and dissociation into single-cell suspension
using TrypLE Express (cat no: 12604013; Thermo Fisher
Scientific) and counted. Cells (10  106) of each condition
were cross-linked with formaldehyde, after which nuclei
were isolated with lysis buffers 1, 2, and 3 as described,43
and sonicated with a Covaris S220 ultrasonicator
(Woburn, MA). The resulting nuclear extract was incubated
with Dynal protein G beads, which were preincubated with
5 mg H3K27me3 (cat no: ab6002; Abcam, Cambridge, UK) or
H3 antibody (cat no: ab1791; Abcam), respectively, at 4C
overnight. After washing and elution of bound complexes
from the beads, cross-links were reversed by heating to
65C. Immunoprecipitation and input DNA then were puri-
fied by treatment with RNase A, proteinase K, and phe-
nol:chloroform extraction. The NEBnext UltraDNA-library
preparation kit for Illumina (cat no: E7805; NEB, Ipswich,
MA) was used to construct libraries from immunoprecipi-
tation and input DNA and subjected to 50-bp, single-end,read sequencing with an Illumina (Ipswich, MA) Hiseq
2000 at EMBL Genecore (Heidelberg, Germany).
Gro-Seq Analysis
ENR500 and RankL-treated organoids were harvested
(as in ChIP-Seq) and GRO-Seq was performed for an equal
number of isolated nuclei. Nuclei extraction and a run-on
reaction were performed as previously established.44 For
each replicate, 3 million cells were suspended to a final
volume of 80–200 mL of freezing buffer. TRIzol LS (cat no:
10296028; Life Technologies, Carlsbad, CA) was used to
extract RNA and fragmented for 13 minutes in 70C using
RNA fragmentation reagents (cat no: AM8740; Life Tech-
nologies), and later purified by running through a RNase-
free P-30 column (cat no: 7326250; Bio-Rad, Hercules,
CA). T4 Polynucleotide Kinase was used to dephosphory-
late RNA for 2 hours (cat no: M02014; New England Bio-
labs, Ipswich, MA), followed by heat-inactivation. A total of
65 mL of blocking solution was added (5 volume of 0.25 
SSPE, 1 mmol/L EDTA, 37.5 mmol/L NaCl, 0.05% Tween-
20, 0.1% Polyvinylpyrrolidone, and 0.1% ultrapure bovine
serum albumin for 1 hour in room temperature), the anti-
bromodeoxyuridine bead slurry (cat no: sc-500780; Santa
Cruz Biotech, Dallas, TX) suspended in 500 mL binding
buffer (0.25  Sodium Chloride-Sodium Phosphate-
EDTA [SSPE], 1 mmol/L EDTA, 37.5 mmol/L NaCl, 0.05%
Table 1.List of Oligonucleotides Primers Used for RT-qPCR



























fwd, forward; rev, reverse.
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tion. After binding for an hour in room temperature, the
beads were washed 2 with binding buffer, 2 with low-
salt buffer (0.2  SSPE, 1 mmol/L EDTA, 0.05% Tween-
20), 1 with high-salt buffer (0.2  SSPE, 1 mmol/L
EDTA, 135 mmol/L NaCl, 0.05% Tween-20), and, lastly, 2
with Tris elution buffer (1  TE, 0.05% Tween-20). The
elution of the RNA was completed with 130 mL elution
buffer (50 mmol/L Tris-HCl, pH 7.5, 150 mmol/L NaCl,
0.1% sodium dodecyl sulfate, 1 mmol/L EDTA, and 20
mmol/L dithiothreitol, followed by ethanol precipitation
overnight. All buffers were supplemented with SUPERase ln
(2 mL/10 mL, cat no: AM2694; Life Technologies). Library
preparations were performed the next day as previously
described.45 The library was amplified with 14 cycles and
the final product of 190–135 bp was extracted from a 10%
Tris/Borate/EDTA gel. The DNA was purified from the gel
using the Gel Extraction Kit (cat no: KO961, ThermoFisher)
and eluted in TE buffer (TE 0.1% Tween þ 150 mmol/L
NaCl). ChIP DNA Clean and Concentrator Kit (cat no: D5205;
Zymo Research Corporation, Irvine, CA) was used to purify
the library, the DNA was quantified with the Qubit fluo-
rometer (Waltham, MA), and sequenced with an Illumina
HiSeq 2000 at EMBL Genecore.
ChIP- and Gro-Seq Data Analyses
Analyses were performed as described previously.27,44,45
The data have been deposited in the NCBI Gene Expression
Omnibus database (GSE157629). Gro-seq and ChIP-seq data
for the individual genes are shown in Supplementary
Tables 1 and 2, respectively.
Immunohistochemistry and Immunofluorescence
PPs from the ileum were isolated and washed with cold
PBS and embedded into paraffin blocks. Sections from the
blocks were rehydrated and washed with PBS. After incu-
bation with 1% PBS/bovine serum albumin supplemented
with 5% normal donkey serum for blocking, antigen
retrieval was processed with citrate buffer, pH 6.0 (121C
for 5 min), and stained overnight at 4C for Esrrg (cat no:
ab49129; Abcam) and GP2 (cat no: D278-3; MBL, Woburn,
MA) antibodies. This was followed by anti-rabbit secondary
for Esrrg (cat no: A32731; ThermoFisher) and anti-rat
secondary for GP2 (cat no: A48261; ThermoFisher). The
sections were examined with a light microscope. For whole-
mount immunostaining, crypt organoids were plated in an
8-well chamber and cultured for 4 days, after which they
were fixed with 4% paraformaldehyde, followed by per-
meabilization with 0.1% Triton (Gibco) X-100. The organo-
ids were stained with the following primary antibodies
overnight at 4C: rabbit anti–Spi-B (Spi-B [D3C5E], cat
no: 14223; CST, Danvers, MA), rabbit anti-Sox8 (cat no:
ab221053; Abcam), and rat anti-GP2 (cat no: D278-3; MBL).
This was followed by incubation with secondary antibody
anti-rabbit Alexa Fluor 568 (cat no: A-11011; Thermo-
Fisher) for Spi-B and Sox8 and anti-rat Alexa Fluor 488 (cat
no: A-11006; ThermoFisher) for GP2. Cells were analyzed
with a Nikon (Melville, NY) A1Rþ Laser Scanning ConfocalMicroscope after mounting with ProLong Diamond with
40,6-diamidino-2-phenylindole mounting solution (cat no:
15810083; ThermoFisher).
Isolation of Villous Epithelium and FAE Cells
Villous epithelium and FAE were prepared by isolating
ileal PPs and small pieces of ileum from the intestine. These
pieces were washed in cold PBS and later incubated in 30
mmol/L EDTA (cat no: 1557-038; Gibco), 5 mmol/L
dithiothreitol (cat number: R0861; ThermoFisher) in PBS,
and gently shaken in ice on a rocker for 20 minutes. After
which, surrounding epithelial cells were peeled off from
lamina propria and PPs. FAE was carefully cleaned off from
surrounding villous epithelium tissues with a 26-gauge
needle under a stereo microscope.
CRISPR–Cas9 Gene Editing of Intestinal
Organoids
Guide RNAs for Rank, Spi-B, and Esrrg were designed
with the CRISPR design tool (http://crispr.mit.edu).46 The
guides were cloned into lentiCRISPR v2 vector (52961;
Addgene, Watertown, MA). The cloned vector was
2021 M Cell Development 887transfected into 293FT cells (cat no: R7007; ThermoFisher)
and the supernatant was collected at 48 hours and
concentrated with Lenti-X concentrator (cat number:
631231; Clontech, Mountain View, CA). The 293FT cell line
was found to be negative for mycoplasma. Cultured intes-
tinal organoids were grown in EGF, Noggin, Chir, Y-27632;
epidermal growth factor, Noggin, Chir-99021 (cat no:
S1263; Selleckchem) and Y-27632 (cat no: 72304; Sell-
eckchem) 2 days before transduction. Organoids were
dissociated into single cells mechanically along with TrypLE
Express (Thermo Fisher Scientific) supplemented with 1000
U/mL DNase I for 5 minutes at 32C. The single-cell sus-
pension was washed once with Advanced Dulbecco’s
modified Eagle medium and resuspended in transduction
medium (ENR media supplemented with 1 mmol/L nico-
tinamide, Y-27632, Chir99021, 8 mg/mL polybrene, cat no:
28728-55-4; Sigma-Aldrich) and mixed with concentrated
virus. The cell–virus mixture was spinoculated for 1 hour at
600  g at 32C followed by a 2- to 4-hour incubation at
37C, after which they were collected and plated on 60%
Matrigel overlaid with transduction medium without poly-
brene. Transduced organoids were selected with 2 rounds
of 2 mg/mL of puromycin (cat no: P8833, 10 mg; Sigma-
Aldrich) on day 2 and day 4, after which clones were
expanded in maintenance ENR medium. KO was confirmed
by Western blot to check for the expression of deleted gene.
Oligonucleotides used for generation of genomic RNAs
were as follows: Esrrg (1) CACCGTCTGTCAA-
GACGGACCCCTG, AACCAGGGGTCCGTCTTGACAGAC, Esrrg
(2) CACCGTGGCGTCGGAAGACCCACCA; AAACCAGGGGT
CCGTCTTGACAGAC. Spi-B (1) CACCGAGACTCCTTCTGGG
TACTGG, AAACCCAGTACCCAGAAGGAGTCTC; and Rank (1)
CACCGAAAGCTAGAAGCACACCAG, AAACCTGGTGTGCTTCT
AGCTTTC.Lentivirus Infection for Overexpression
RelB, p52, RelA, and p50 plasmids were a gift from
Hiroshi Ohno’s laboratory (RCIMS, Kangawa, Japan) and
Esrrg complementary DNA was cloned by Twist Bioscience
(San Francisco, CA). These were cloned into CSII-CMV-MCS-
IRES2-Bsd vector, which was kindly provided by the RIKEN
Bioresource Center (Ibaraki, Japan) and Hiroyuki Miyoshi.
The same protocol for Crispr-Cas9 lentiviral generation and
transduction was followed and cells were embedded into
Matrigel and incubated for 2–3 days.Immunoblotting
Organoids were recovered from Matrigel with Cell Re-
covery media (cat no: 354253; Corning). Organoids were
washed with PBS and the cells were lysed with 2 Laemmli
solution and boiled at 98ºC. Protein concentrations were
measured by a Pierce (Waltham, MA) 660 nm Protein Assay
Reagent and IDCR (cat no: 22660; ThermoFisher Scientific).
Samples were loaded equally in terms of protein concen-
tration into 10% Bis-Tris protein gels (cat no: 4561033; Bio-
Rad) and blotted on nitrocellulose membranes. Membranes
were incubated with primary antibodies: anti-Esrrg (cat no:ab49129; Abcam); anti–Spi-B (Spi-B D4V9S, cat no: 14337;
CST); anti-H3K27me3 (cat no: ab192985; Abcam); anti-H3
(cat no: ab1791; Abcam), anti-Rank (cat no: MBS9133424;
MyBioSource, San Diego, CA), and anti-glyceraldehyde-3-
phosphate dehydrogenase (cat no: ab8245; Abcam) at 4C
overnight, and horseradish-peroxidase–conjugated anti-
rabbit (1:5000, cat no: RABHRP1-10UL; Sigma-Aldrich) or
anti-mouse (1:1000, cat no: 7076; CST) for 1 hour at room
temperature. Signal was detected using ECL reagent (cat no:
2232; Amersham, Amersham, UK).Real-Time RT-qPCR
Total RNA was prepared using TRIzol (cat no:
15596018; Life Technologies) from intestinal organoids and
epithelium isolated from mice. Isolated RNA was tran-
scribed to first-strand complementary DNA using the iScript
complementary DNA synthesis kit (1708891; Bio-Rad).
qPCR amplification was detected using Ssofast evergreen
supermixes (172-5203; Bio-Rad). The specific primers used
are listed in Table 1.Data Availability
The ChIP-seq and Gro-seq data have been deposited in
the NCBI Gene Expression Omnibus database (GSE157629).References
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